Get started
Author

Sharif Uddin

Observed names: S Uddin, Sharif M Uddin, Sharif M. Uddin, Uddin, Sharif
ORCID: 0000-0002-0268-2178
Observed ORCID: 0000-0002-0268-2178
OpenAlex ID: A5082004256
Validation of the Knee Injury and Osteoarthritis Outcome Score Subscales for Patients With Articular Cartilage Lesions of the Knee
2012 · Luella Engelhart, Lauren Nelson, et al. · The American Journal of Sports Medicine · 83
Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR
2016 · Robert D. Murray, Bertil Ekman, et al. · Clinical Endocrinology · 60
PDF
Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency
2016 · Marcus Quinkler, Bertil Ekman, et al. · Endocrine Connections · 59
PDF
Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study
2017 · Anna G Nilsson, Ragnhildur Bergthorsdottir, et al. · European Journal of Endocrinology · 39
PDF
Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn’s Disease: Post Hoc Analyses of VISIBLE Studies
2023 · William J Sandborn, Jingjing Chen, et al. · Crohn s & Colitis 360 · 9
PDF
Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma
2020 · Patrick Martin, Alisa Cohen, et al. · Clinical ophthalmology · 9
PDF
Effects of Teduglutide on Diarrhea in Pediatric Patients with Short Bowel Syndrome‐Associated Intestinal Failure
2023 · Amanda Fifi, Bram P. Raphael, et al. · Journal of Pediatric Gastroenterology and Nutrition · 8
An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study
2022 · Roger S McIntyre, Orly Lipsitz, et al. · JMIR Mental Health · 7
PDF
Clinical Trial Design in Ulcerative Colitis: Interpreting Evolving Endpoints Based on Post Hoc Analyses of the Vedolizumab Phase 3 Trials GEMINI 1 and VISIBLE 1
2023 · William J Sandborn, Bruce E Sands, et al. · Crohn s & Colitis 360 · 4
P510 Dose escalation of subcutaneous vedolizumab in patients with ulcerative colitis: A post hoc analysis of the VISIBLE trial data
2020 · W Sandborn, D Wolf, et al. · Journal of Crohn s and Colitis · 4
PDF
Clinical Features at Baseline are Not Clearly Associated with Symptomatic Placebo Response in Adolescents and Adults with Eosinophilic Esophagitis During a Placebo Run-in Period of a Double-Blind, Randomized, Controlled Trial of Budesonide Oral Suspension
2017 · Ikuo Hirano, James Williams, et al. · Gastroenterology · 4
An open-label phase 2 trial to assess the efficacy, safety and pharmacokinetics of lanthanum carbonate in hyperphosphatemic children and adolescents with chronic kidney disease undergoing dialysis
2022 · Anna Wasilewska, Rose Ann Murray, et al. · BMC Nephrology · 3
PDF
Sa1880 DOSE ESCALATION OF SUBCUTANEOUS VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS: A POST HOC ANALYSIS OF THE VISIBLE TRIAL DATA
2020 · William J. Sandborn, Douglas C. Wolf, et al. · Gastroenterology · 2
Su565 REAL-WORLD EFFECTIVENESS AND SAFETY OF TEDUGLUTIDE IN ADULT SHORT BOWEL SYNDROME: A META-ANALYSIS
2021 · Shirley Paski, Bram P. Raphael, et al. · Gastroenterology · 1
Sa1879 EFFICACY AND SAFETY OF VEDOLIZUMAB REINITIATION FOLLOWING TREATMENT INTERRUPTION: POST HOC ANALYSIS OF THE VISIBLE TRIAL DATA
2020 · William J. Sandborn, Silvio Danese, et al. · Gastroenterology · 1
Hormone replacement therapy with prednisolone in adrenal insufficiency patients: data from the European Adrenal Insufficiency Registry (EuAIR)
2015 · Marcus Quinkler, Bertil Ekman, et al. · Endocrine Abstracts · 1
Effect of teduglutide treatment on stool characteristics in children with short bowel syndrome-associated intestinal failure and colon-in-continuity
2025 · Susan Hill, Beth Carter, et al. · Intestinal failure.
PDF
Tu1741 EFFICACY AND SAFETY OUTCOMES IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS STRATIFIED BY ETHNICITY AND RACE: A POOLED ANALYSIS OF DATA FROM GEMINI 1, VARSITY, AND VISIBLE 1
2023 · Richa S. Mukherjee, Qasim Rana Khan, et al. · Gastroenterology
PDF
P466 Efficacy and safety outcomes in patients with moderate to severe ulcerative colitis stratified by ethnicity and race: a pooled analysis of data from GEMINI 1, VARSITY, and VISIBLE 1
2023 · R Mukherjee, R M Q Khan, et al. · Journal of Crohn s and Colitis
PDF
P854 Race and ethnicity in ulcerative colitis clinical trial enrolment: a post hoc analysis of patient demographics and clinical characteristics from GEMINI 1, VARSITY, and VISIBLE 1
2023 · R M Q Khan, A N Ananthakrishnan, et al. · Journal of Crohn s and Colitis
PDF
P814 Clinical trial design in Crohn’s disease: interpreting future endpoints based on post hoc analyses of the vedolizumab phase 3 trials GEMINI 2 and VISIBLE 2
2023 · R M Q Khan, D A Schwartz, et al. · Journal of Crohn s and Colitis
PDF
S983 Baseline Demographics and Disease Characteristics of Patients With Ulcerative Colitis Who Responded to Vedolizumab at Week 6
2022 · Andres Yarur, Vipul Jairath, et al. · The American Journal of Gastroenterology
S875 The Evolution of Clinical Trial Design in Ulcerative Colitis: Interpreting Future Endpoints Based on Post-Hoc Analyses of the Vedolizumab Phase 3 Trials GEMINI 1 and VISIBLE 1
2021 · William J. Sandborn, Bruce E. Sands, et al. · The American Journal of Gastroenterology
P366 Vedolizumab maintenance therapy reduced use of corticosteroids in patients with Crohn’s disease in the GEMINI 2 trial
2021 · G D’Haens, N Candela, et al. · Journal of Crohn s and Colitis
PDF
A Phase 3b, open-label, extension study to evaluate the long-term safety of once-daily, dual-release hydrocortisone (DR-HC) in patients with adrenal insufficiency (AI)
2016 · Anna Nilsson, Ragnhildur Bergthorsdottir, et al. · Endocrine Abstracts
PDF
Works count: 33
Citation count: 294
H-index: 7
I10-index: 4
Year
Topic
Type